These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 929137)

  • 1. [Aldosterone and renin in liver cirrhosis with ascites].
    Vetter H; Vetter W; Beckerhoff R; Glänzer K; Furrer J; Hahn C; Kolloch R; Krück F; Kutz K; Siegenthaler W; Witassek F
    Schweiz Med Wochenschr; 1977 Dec; 107(48):1755-9. PubMed ID: 929137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of renin and aldosterone in cirrhotic patients with ascites.
    Rosoff L; Zia P; Reynolds T; Horton R
    Gastroenterology; 1975 Sep; 69(3):698-705. PubMed ID: 1158087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Components of the renin-angiotensin-aldosterone system in plasma and ascites in hepatic cirrhosis.
    Kuiper JJ; Boomsma F; van Buren H; de Man R; Danser AH; van den Meiracker AH
    Eur J Clin Invest; 2008 Dec; 38(12):939-44. PubMed ID: 19021719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels of atrial natriuretic peptide in compensated and decompensated cirrhosis of the liver. Relationship with the renin-aldosterone system.
    Colantonio D; Casale R; Pasqualetti P
    Panminerva Med; 1989; 31(4):166-70. PubMed ID: 2534427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cirrhotic ascites and the renin-angiotensin system].
    Gonvers JJ; Loup P; Hofstetter JR; Brunner HR
    Schweiz Med Wochenschr; 1980 May; 110(22):869-71. PubMed ID: 6996085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The renin-angiotensin-aldosterone system in decompensated cirrhosis: its activity in relation to sodium balance.
    Sellars L; Shore AC; Mott V; Wilkinson R
    Q J Med; 1985 Aug; 56(220):485-96. PubMed ID: 3901077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interrelationship between atrial natriuretic peptide and plasma renin, aldosterone and catecholamines in hepatic cirrhosis: the effect of passive leg rising.
    Burghardt W; Müller R; Diehl KL; Wernze H
    Z Kardiol; 1988; 77 Suppl 2():104-10. PubMed ID: 2970163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biological factors influencing response to diuretics in patients with cirrhosis and ascites].
    Lenaerts A; Codden T; Henry JP; Van Cauter J; Meunier JC; Ligny G
    Gastroenterol Clin Biol; 2001 Mar; 25(3):268-72. PubMed ID: 11395674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The renal and hemodynamic effects of the peritoneovenous shunt for intractable hepatic ascites.
    Blendis LM; Greig PD; Langer B; Baigrie RS; Ruse J; Taylor BR
    Gastroenterology; 1979 Aug; 77(2):250-7. PubMed ID: 447039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal hemodynamics and the renin-angiotensin system in cirrhosis.
    Aliaga L; Zozaya JM; Quiroga J; Richter JA; Prieto J
    Rev Esp Fisiol; 1989; 45 Suppl():371-5. PubMed ID: 2701770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal effects of treatment with diuretics, octreotide or both, in non-azotemic cirrhotic patients with ascites.
    Kalambokis G; Economou M; Fotopoulos A; Bokharhii JA; Katsaraki A; Tsianos EV
    Nephrol Dial Transplant; 2005 Aug; 20(8):1623-9. PubMed ID: 15886218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
    Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of beta adrenergic blocking drugs on the renin-aldosterone system, sodium excretion, and renal hemodynamics in cirrhosis with ascites.
    Wilkinson SP; Bernardi M; Smith IK; Jowett TP; Slater JD; Williams R
    Gastroenterology; 1977 Oct; 73(4 Pt 1):659-63. PubMed ID: 19338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nadolol plus spironolactone in the prophylaxis of first variceal bleed in nonascitic cirrhotic patients: A preliminary study.
    Abecasis R; Kravetz D; Fassio E; Ameigeiras B; Garcia D; Isla R; Landeira G; Dominguez N; Romero G; Argonz J; Terg R
    Hepatology; 2003 Feb; 37(2):359-65. PubMed ID: 12540786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of clonidine on diuretic response in ascitic patients with cirrhosis and activation of sympathetic nervous system.
    Lenaerts A; Codden T; Meunier JC; Henry JP; Ligny G
    Hepatology; 2006 Oct; 44(4):844-9. PubMed ID: 17006921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic value of the renin-angiotensin system in response to salt restriction and prognosis of alcoholic ascitic cirrhosis].
    Genoud E; Gonvers JJ; Schaller MD; Essinger A; Haller E; Brunner HR
    Schweiz Med Wochenschr; 1986 Apr; 116(15):463-9. PubMed ID: 3518053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Relationship between the diuretic response and the activity of the renin-aldosterone system.
    Pérez-Ayuso RM; Arroyo V; Planas R; Gaya J; Bory F; Rimola A; Rivera F; Rodés J
    Gastroenterology; 1983 May; 84(5 Pt 1):961-8. PubMed ID: 6339312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative pharmacodynamics of furosemide and muzolimine in cirrhosis. Study on renal sodium and potassium handling and renin-aldosterone axis.
    Bernardi M; De Palma R; Trevisani F; Santini C; Servadei D; Gasbarrini G
    Z Kardiol; 1985; 74 Suppl 2():129-34. PubMed ID: 3890391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-6, nitric oxide, and the clinical and hemodynamic alterations of patients with liver cirrhosis.
    Genesca J; Gonzalez A; Segura R; Catalan R; Marti R; Varela E; Cadelina G; Martinez M; Lopez-Talavera JC; Esteban R; Groszmann RJ; Guardia J
    Am J Gastroenterol; 1999 Jan; 94(1):169-77. PubMed ID: 9934750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction in hepatic venous pressure gradient as a consequence of volume contraction due to chronic administration of spironolactone in patients with cirrhosis and no ascites.
    Okumura H; Aramaki T; Katsuta Y; Satomura K; Akaike M; Sekiyama T; Terada H; Ohsuga M; Komeichi H; Tsutsui H
    Am J Gastroenterol; 1991 Jan; 86(1):46-52. PubMed ID: 1986554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.